Evaluation of Neoadjuvant Xaluritamig in Localized Prostate Cancer

Clinical trial NCT06613100 · RECRUITING

Trial details

NCT number: NCT06613100
Sponsor: Amgen
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2024-11-25
Primary completion: 2027-02-17
Enrollment: 40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.